Eli Lilly Reaches Historic $1 Trillion Valuation Milestone
Published on 11/21/2025 at 22:41 | Redaktion boerse-global.de
The pharmaceutical sector has reached an unprecedented milestone as Eli Lilly becomes the first drugmaker to achieve a $1 trillion market capitalization, a valuation realm traditionally dominated by technology giants. This historic achievement stems from the company’s commanding position in a rapidly expanding market that touches millions of lives globally.
Eli Lilly’s remarkable ascent is primarily driven by its highly successful portfolio of diabetes and obesity medications. The company’s third-quarter financial results revealed that the combined revenue from Mounjaro and Zepbound surpassed $10 billion, accounting for more than half of the corporation’s total earnings.
Key performance indicators demonstrate extraordinary momentum:
• Mounjaro generated $6.52 billion in Read more...
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
